Irreversible electroporation for the management of pancreatic cancer: Current data and future directions.
Ablation
Image-guided treatment
Interventional oncology
Irreversible electroporation
Loco-regional treatment
Pancreatic cancer
Journal
World journal of gastroenterology
ISSN: 2219-2840
Titre abrégé: World J Gastroenterol
Pays: United States
ID NLM: 100883448
Informations de publication
Date de publication:
14 Jan 2023
14 Jan 2023
Historique:
received:
28
09
2022
revised:
13
11
2022
accepted:
21
12
2022
entrez:
23
1
2023
pubmed:
24
1
2023
medline:
25
1
2023
Statut:
ppublish
Résumé
Pancreatic cancer is currently the seventh leading cause of cancer death (4.5% of all cancer deaths) while 80%-90% of the patients suffer from unresectable disease at the time of diagnosis. Prognosis remains poor, with a mean survival up to 15 mo following systemic chemotherapy. Loco-regional thermal ablative techniques are rarely implemented due to the increased risk of thermal injury to the adjacent structures, which can lead to severe adverse events. Irreversible electroporation, a promising novel non-thermal ablative modality, has been recently introduced in clinical practice for the management of inoperable pancreatic cancer as a safer and more effective loco-regional treatment option. Experimental and initial clinical data are optimistic. This review will focus on the basic principles of IRE technology, currently available data, and future directions.
Identifiants
pubmed: 36687122
doi: 10.3748/wjg.v29.i2.223
pmc: PMC9846938
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
223-231Informations de copyright
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Références
J Vasc Interv Radiol. 2013 Nov;24(11):1709-18
pubmed: 23891044
IEEE Trans Biomed Eng. 2006 Jul;53(7):1409-15
pubmed: 16830945
J Vasc Interv Radiol. 2017 Mar;28(3):342-348
pubmed: 27993507
Anticancer Res. 2019 May;39(5):2509-2512
pubmed: 31092446
J Surg Oncol. 2016 Dec;114(7):865-871
pubmed: 27546233
Cancer Lett. 2012 Apr 1;317(1):16-23
pubmed: 22079741
Ann Surg. 2015 Sep;262(3):486-94; discussion 492-4
pubmed: 26258317
J Cancer Res Ther. 2021 Jul;17(3):613-618
pubmed: 34269289
Nat Commun. 2019 Feb 22;10(1):899
pubmed: 30796212
HPB (Oxford). 2019 Aug;21(8):1024-1031
pubmed: 30737097
Pancreas. 2021 Oct 1;50(9):1281-1286
pubmed: 34860812
Curr Pharm Des. 2015;21(10):1249-55
pubmed: 25506899
Sci Rep. 2021 Apr 7;11(1):7584
pubmed: 33828203
Nanomedicine (Lond). 2014;9(8):1181-92
pubmed: 24024571
World J Gastrointest Oncol. 2018 Dec 15;10(12):476-486
pubmed: 30595801
J Vis Exp. 2018 Jun 8;(136):
pubmed: 29939178
Radiology. 2020 May;295(2):254-272
pubmed: 32208094
Front Oncol. 2020 Jan 22;10:6
pubmed: 32038984
Immunol Lett. 2017 Jun;186:20-27
pubmed: 28392199
Hepatobiliary Surg Nutr. 2015 Jun;4(3):211-5
pubmed: 26151062
Pancreas. 2015 Jul;44(5):791-8
pubmed: 25931252
J Surg Oncol. 2011 Jul 1;104(1):22-8
pubmed: 21360714
J Vasc Interv Radiol. 2012 Dec;23(12):1613-21
pubmed: 23177107
Cancers (Basel). 2021 Aug 04;13(16):
pubmed: 34439081
J Clin Med. 2021 Apr 10;10(8):
pubmed: 33920118
Technol Cancer Res Treat. 2007 Aug;6(4):287-94
pubmed: 17668935
Cancers (Basel). 2019 Nov 03;11(11):
pubmed: 31684186
Radiology. 2020 Jan;294(1):212-220
pubmed: 31687922
Biophys J. 1974 Nov;14(11):881-99
pubmed: 4611517
Oncoimmunology. 2021 Feb 2;10(1):1875638
pubmed: 33643692
Eur J Surg Oncol. 2014 Dec;40(12):1598-604
pubmed: 25307210
BMJ Open. 2022 May 12;12(5):e050166
pubmed: 35551086
Technol Cancer Res Treat. 2007 Feb;6(1):37-48
pubmed: 17241099
Signal Transduct Target Ther. 2020 Oct 23;5(1):215
pubmed: 33093457
Int J Surg. 2015 Sep;21 Suppl 1:S34-9
pubmed: 26118600
Front Oncol. 2022 May 25;12:843769
pubmed: 35692753
Cancers (Basel). 2020 Jul 03;12(7):
pubmed: 32635230
Technol Cancer Res Treat. 2007 Aug;6(4):307-12
pubmed: 17668938
J Vasc Interv Radiol. 2012 Jan;23(1):107-13
pubmed: 22137466
Semin Intervent Radiol. 2019 Dec;36(5):386-391
pubmed: 31798212
Lancet Oncol. 2016 Jun;17(6):801-810
pubmed: 27160474
Med Biol Eng Comput. 2017 Jul;55(7):1123-1127
pubmed: 28078482
Mol Ther Methods Clin Dev. 2015 Mar 04;2:15001
pubmed: 26029712
Cell Physiol Biochem. 2018;48(5):1882-1893
pubmed: 30092590
Tech Vasc Interv Radiol. 2020 Jun;23(2):100675
pubmed: 32591191
Front Oncol. 2021 Sep 10;11:712042
pubmed: 34568040
Cancers (Basel). 2018 Jan 10;10(1):
pubmed: 29320420
Radiology. 2010 May;255(2):426-33
pubmed: 20413755
CA Cancer J Clin. 2017 Jan;67(1):7-30
pubmed: 28055103
Front Oncol. 2020 Jul 28;10:1235
pubmed: 32850371
J Am Coll Surg. 2012 Sep;215(3):361-9
pubmed: 22726894
Pancreatology. 2020 Apr;20(3):470-476
pubmed: 32033896
HPB (Oxford). 2010 Jun;12(5):348-51
pubmed: 20590911